Skip to main content
Vivimed Labs Ltd. logo

Vivimed Labs Ltd. — Investor Relations & Filings

Ticker · VIVIMEDLAB ISIN · INE526G01021 LEI · 335800LYN9TN3F87WV86 BSE.NS Manufacturing
Open in API
Filings indexed 861 across all filing types
Latest filing 2023-11-14 Regulatory Filings
Country IN India
Listing BSE.NS VIVIMEDLAB

About Vivimed Labs Ltd.

http://www.vivimedlabs.com/

Vivimed Labs Ltd. specializes in the development and manufacture of active pharmaceutical ingredients (APIs), finished dosage formulations (FDF), and specialty chemicals. The company provides contract research and manufacturing services (CRAMS) and produces generic medicines across various therapeutic areas. Its specialty chemicals division focuses on niche products, including photochromic dyes for ophthalmic lenses, hair colorants, and anti-microbial agents for personal care and industrial use. Vivimed operates research and development centers and manufacturing facilities that adhere to international regulatory standards, catering to a global customer base in the healthcare and chemical sectors.

Recent filings

Filing Released Lang Actions
Financial Result Updates
Regulatory Filings
2023-11-14 English
Shareholders meeting
Regulatory Filings Classification · 90% confidence The document text contains only references to omitted pictures and no textual content or substantive information. The true document length is only 224 characters, which is extremely short and contains no report or announcement content. There is no indication of any report, announcement, or filing type. Given the lack of content, this document cannot be classified as a substantive report or announcement. It fits best as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings without clear classification.
2023-11-14 English
Proceedings of the 35th Annual General Meeting.
Regulatory Filings
2023-11-14 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document text contains only placeholders for images and no substantive text or financial data. The true document length is only 111 characters, indicating it is extremely short and does not contain any report content. There is no indication of any report, announcement, or filing type. Given the lack of content, the document cannot be classified as a report or announcement and falls under the fallback category of Regulatory Filings (RNS).
2023-10-28 English
VIVIMED LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 of ....
Regulatory Filings
2023-10-28 English
Shareholders meeting
Regulatory Filings
2023-10-20 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.